An index-based search to scientific computing applications while at the same time maintaining the benefits of hyper-scalability and ease of implementation.
BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the first patient was enrolled in a Phase 3 clinical trial in China of pamiparib (BGB-290), an investigational PARP inhibitor, in patients with platinum-sensitive recurrent ovarian cancer
PerkinElmer Signals™ Notebook is a powerful new web based Electronic Lab Notebook, enabling users to instantly author and manage notebooks and experiments, facilitating Scientific Collaboration.
At Finesse, our goal is to enable customers to quickly and efficiently manufacture innovative drugs and vaccines. The SmartRocker, SmartBag, SmartPuck and SmartReader combination brings next generation control and measurement to rocking bioreactor applications. A SmartRocker is controlled by a G3Lab™ Universal SmartController and Finesse TruBio® software. This turnkey package provides a complete solution for research, process development, or seed train production applications.
Leading Analytical Scientists with Advanced Instrumentation.
This XDR single-use bioreactor is sized for the benchtop, yet allows smooth scale-up to full production.
The ZE5 Cell Analyzer is an innovative new flow cytometer with flexible configurations to meet a broad range of experimental complexities and throughput needs. Whether it’s a low-complexity, or a high-complexity experiment, the ZE5 Analyzer has up to 30 parameters and provides a truly expandable flow cytometer. This flexibility makes the ZE5 Analyzer accessible for novice flow cytometry users yet flexible enough for the most experienced flow cytometry professionals
